Literature DB >> 21895787

Species assignment and antifungal susceptibilities of black aspergilli recovered from otomycosis cases in Iran.

Gyöngyi Szigeti1, Ebrahim Sedaghati, Ali Zarei Mahmoudabadi, Ali Naseri, Sándor Kocsubé, Csaba Vágvölgyi, János Varga.   

Abstract

Black aspergilli are among the main causative agents of otomycosis worldwide. In this study, the species assignment of black aspergilli isolated from otomycosis cases in Iran was carried out using sequence analysis of part of the calmodulin gene. The results indicate that Aspergillus niger is not the only black Aspergillus species involved in otomycosis cases in Iran: Aspergillus awamori and Aspergillus tubingensis are also able to cause ear infections. Antifungal susceptibility tests were carried out against five antifungal drugs including amphotericin B, fluconazole, itraconazole, ketoconazole and terbinafine. All isolates were highly susceptible to terbinafine, while they exhibited moderate susceptibilities against amphotericin B, fluconazole and ketoconazole. Aspergillus niger and A. awamori were found to have higher minimal inhibitory concentrations for azoles than A. tubingensis, in accordance with previous findings.
© 2011 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21895787     DOI: 10.1111/j.1439-0507.2011.02103.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  17 in total

Review 1.  Otomycosis in iran: a review.

Authors:  Maral Gharaghani; Zahra Seifi; Ali Zarei Mahmoudabadi
Journal:  Mycopathologia       Date:  2015-01-30       Impact factor: 2.574

2.  Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis.

Authors:  Keyvan Kiakojuri; Saeid Mahdavi Omran; Somayeh Roodgari; Mojtaba Taghizadeh Armaki; Mohammad Taghi Hedayati; Tahereh Shokohi; Iman Haghani; Javad Javidnia; Firoozeh Kermani; Hamid Badali; Mahdi Abastabar
Journal:  Mycopathologia       Date:  2021-03-15       Impact factor: 2.574

3.  Identification and susceptibility of Aspergillus section nigri in china: prevalence of species and paradoxical growth in response to echinocandins.

Authors:  Yali Li; Zhe Wan; Wei Liu; Ruoyu Li
Journal:  J Clin Microbiol       Date:  2014-12-10       Impact factor: 5.948

4.  Molecular identification and antifungal susceptibilities of black Aspergillus isolates from otomycosis cases in Hungary.

Authors:  Gyöngyi Szigeti; Sándor Kocsubé; Ilona Dóczi; László Bereczki; Csaba Vágvölgyi; János Varga
Journal:  Mycopathologia       Date:  2012-02-23       Impact factor: 2.574

5.  Aspergillus luchuensis, an industrially important black Aspergillus in East Asia.

Authors:  Seung-Beom Hong; Mina Lee; Dae-Ho Kim; Janos Varga; Jens C Frisvad; Giancarlo Perrone; Katsuya Gomi; Osamu Yamada; Masayuki Machida; Jos Houbraken; Robert A Samson
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

6.  New and revisited species in Aspergillus section Nigri.

Authors:  J Varga; J C Frisvad; S Kocsubé; B Brankovics; B Tóth; G Szigeti; R A Samson
Journal:  Stud Mycol       Date:  2011-06-30       Impact factor: 16.097

7.  Otomycosis in Damascus, Syria: Etiology and clinical features.

Authors:  Mohammad T Ismail; Abeer Al-Kafri; Mazen Ismail
Journal:  Curr Med Mycol       Date:  2017-09

8.  Lamisil versus clotrimazole in the treatment of vulvovaginal candidiasis.

Authors:  Ali Zarei Mahmoudabadi; Mahin Najafyan; Eskandar Moghimipour; Maryam Alwanian; Zahra Seifi
Journal:  Iran J Microbiol       Date:  2013-03

9.  Involvement of the opportunistic pathogen Aspergillus tubingensis in osteomyelitis of the maxillary bone: a case report.

Authors:  Erik Bathoorn; Natalia Escobar Salazar; Shahrzad Sepehrkhouy; Martin Meijer; Hans de Cock; Pieter-Jan Haas
Journal:  BMC Infect Dis       Date:  2013-02-01       Impact factor: 3.090

10.  Etiologic Agents of Otomycosis in the North-Western Area of Iran.

Authors:  Abdolhassan Kazemi; Maryam Majidinia; Abbasali Jaafari; Seyyed Amin Ayatollahi Mousavi; Ali Zarei Mahmoudabadi; Hossein Alikhah
Journal:  Jundishapur J Microbiol       Date:  2015-09-08       Impact factor: 0.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.